Duquesne
TXG · Medicine & biotech

10x Genomics

Makes lab tools that let scientists study cells one by one.
New: first time
Duquesne bought 10x Genomics for the first time between April and June: 403,100 shares, worth about $15 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
403,100

The numbers

Shares they own
403,100
Value on Jun 30, 2026
$15,455,000
about $15 million
Share of their money
0.4%
less than $1 of every $100 · 55th of 85
Price per share on Jun 30
$38.34
Kind
Shares
Also owned by
No other fund we follow
More about 10x Genomics
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works